<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82142">
  <stage>Registered</stage>
  <submitdate>8/07/2007</submitdate>
  <approvaldate>24/02/2014</approvaldate>
  <actrnumber>ACTRN12614000194662</actrnumber>
  <trial_identification>
    <studytitle>Oral sucrose for pain relief in children undergoing bladder catheterization.</studytitle>
    <scientifictitle>In children undergoing bladder catheterization, does oral sucrose compared to placebo, reduce pain and distress caused by the procedure?</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Pain experienced during bladder catheterization.</healthcondition>
    <conditioncode>
      <conditioncode1>Renal and Urogenital</conditioncode1>
      <conditioncode2>Other renal and urogenital disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Intervention - 4 mLs of 75% sucrose administered orally once only prior to bladder catheterisation. Participants are reviewed immediately following the procedure.
</interventions>
    <comparator>Placebo - 4mL of water administered orally</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Crying time</outcome>
      <timepoint>Duration of first cry, total sum of crying time and total duration of crying immediately following bladder catheterization.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Heart rate measured by pulse oximetry.</outcome>
      <timepoint>Difference in heart rate before (5 min prior to catheter) and after bladder catheterisation (1 min immediately after catheter).</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>FLACC and OUCHER pain scales</outcome>
      <timepoint>Immediately before, during and immediately after bladder catheterisation.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Nil.</outcome>
      <timepoint>Nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Infants or children requiring bladder catheterisation for diagnosis of suspected urinary tract infection.
Have not achieved bladder control.</inclusivecriteria>
    <inclusiveminage>3</inclusiveminage>
    <inclusiveminagetype>Months</inclusiveminagetype>
    <inclusivemaxage>4</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Unable to tolerate oral fluids. Unsuccessful first attempt at bladder catheterisation. Toilet trained. Oral sucrose is contraindicated (eg diabetic ketoacidosis). Altered neurological state (eg moribund, neurological conditions).</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Once a patient is identified as potentially eligible for the study, a co-investigator is contacted who confirms eligibility. Allocation occurs by numbered envelopes containing pre-filled syringes of either sucrose (active treatment) or water (placebo). Both sucrose and water are clear, colourless solutions and are unable to be differentiated by their appearance. The co-investigator is blinded to the order of the treatment/placebo allocation sequence.</concealment>
    <sequence>Permuted block randomization by computerized random number generation.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1>True</masking1>
    <masking2>True</masking2>
    <masking3>True</masking3>
    <masking4>True</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/06/2006</anticipatedstartdate>
    <actualstartdate>9/06/2006</actualstartdate>
    <anticipatedenddate />
    <actualenddate>18/06/2010</actualenddate>
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW</recruitmentstate>
    <hospital>Nepean Hospital - Kingswood</hospital>
    <postcode>2750 - Penrith</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Ralph Nanan</primarysponsorname>
    <primarysponsoraddress>Level 5, South Block
Nepean Hospital
Derby St
Penrith NSW, 2750</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Nepean Hospital Paediatric Department</fundingname>
      <fundingaddress>Derby St, 
Penrith NSW, 2750</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>Nil.</sponsorname>
      <sponsoraddress>Nil</sponsoraddress>
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study is to determine if oral sucrose is useful at reducing the pain and distress caused by bladder catheterisation in children. This is a common and important procedure, often required to diagnose urine infections in children, and currently there is no effective, practical methods proven to reduce the pain caused by this procedure.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Nepean Hospital Human Research Ethics Committee</ethicname>
      <ethicaddress>Ethics Office
Nepean Hospital
Derby St
Penrith NSW, 2750</ethicaddress>
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Anthony Liu</name>
      <address>Paediatric Department
Level 5
South Block
Nepean Hospital
Derby St
Penrith NSW 2750</address>
      <phone>61247343363</phone>
      <fax />
      <email>anthony.liu@health.nsw.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Anthony Liu</name>
      <address>Paediatric Department
Level 5
South Block
Nepean Hospital
Derby St
Penrith NSW 2750</address>
      <phone>61247343363</phone>
      <fax />
      <email>anthony.liu@health.nsw.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Anthony Liu</name>
      <address>Paediatric Department
Level 5
South Block
Nepean Hospital
Derby St
Penrith NSW 2750</address>
      <phone>61247343363</phone>
      <fax />
      <email>anthony.liu@health.nsw.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Ralph Nanan</name>
      <address>Level 5, South Block
Nepean Hospital
Derby St
Penrith NSW, 2750</address>
      <phone>61247343363</phone>
      <fax />
      <email>ralph.nanan@sydney.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>